 2020 Third Quarter Earnings Call Summary for Chemed Corporation

Chemed Corporation reported its third quarter 2020 financial results, which showed operational improvement and sequential growth in both its hospice and plumbing services segments. VITAS Healthcare Corporation, Chemed's hospice segment, saw admissions increase by 4.7% in the third quarter, with a slight decline in average daily census. Roto-Rooter, Chemed's plumbing services segment, saw unit-for-unit commercial demand decline 11.6% in the third quarter when compared to the prior year, but this was an improvement from the 29.1% decline in the second quarter. Chemed is estimating full year 2020 revenue growth of 12.5% to 13.5% for Roto-Rooter, and VITAS is forecasted to achieve full year 2020 revenue growth of 4%. Chemed's full year 2020 adjusted earnings per diluted share, excluding non-cash expense for stock options, tax benefits for stock options, costs related to litigation and other discrete items, is estimated to be in the range of $18 to $18.15.